Form D · Pharmaceuticals
Clearside Biomedical, Inc.
Alpharetta, 2Q · CIK 0001539029
Offering snapshot reported Dec 4, 2019 · SEC filing
- Reported sold
- $3.35M Offering amount: $3.35M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 26, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 4, 2019 | Initial | $3,349,999 | No comparison | 3 | SEC filing |
| Oct 13, 2016 | Initial | $320,009 | No comparison | 2 | SEC filing |
| Dec 8, 2015 | Initial | $14,449,993 | No comparison | 9 | SEC filing |
| Sep 15, 2014 | Initial | $16,211,809 | No comparison | 31 | SEC filing |
| May 12, 2014 | Initial | $2,999,997 | No comparison | 13 | SEC filing |
| Feb 12, 2013 | Initial | $7,899,987 | No comparison | 13 | SEC filing |
| Feb 16, 2012 | Amendment | $3,233,777 | $2,033,085vs Jan 9, 2012 | 7 | SEC filing |
| Jan 9, 2012 | Initial | $1,200,692 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-354771
Source: Form D, filed Dec 4, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jerry Cagle | Director |
| Gerald D. Cagle | Director |
| Gerald D. Cagle, Ph.D. | Director |
| Richard Croarkin | Director |
| Charlie Deignan | Executive |
| Charles A. Deignan | Executive |
| Jeffrey L. Edwards | Director |
| William D. Humphries | Director |
| George Lasezkay | Director, Executive |
| Glenn Noronha | Executive |
| Mark Prausnitz | Director, Promoter |
| Christy L. Shaffer | Director |
| Christy L. Shaffer, Ph.D. | Director |
| Clay B. Thorp | Director |
| Daniel H. White | Director, Executive |
| Derek Yoon | Director |
| Evgeny Zaytsev | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
900 North Point Parkway Suite 200
Alpharetta, 2Q, 30005
Alpharetta, 2Q, 30005